The Biden administration appoints a new coordinator for its global coronavirus response; more infectious COVID-19 variant first identified in United Kingdom now in all 50 states; spotlighting the impact of COVID-19 on the heart of an athlete.
In an effort to combat growing concerns of vaccine inequity worldwide, the Biden administration announced yesterday the appointment of Gayle Smith, a former director of the US Agency for International Development, to serve as the new coordinator for its global coronavirus response. Reported by The Washington Post, part of Smith’s responsibility will be to mobilize US resources and bolster vaccine production and distribution across the world. Globally, COVID-19 deaths surpassed 3 million today, with Brazil and India currently experiencing significant spikes in cases and deaths.
Reported by CNN, the COVID-19 variant first identified in the United Kingdom, B117, has now been identified in all 50 states, with more than 15,000 cases reported nationwide. Noted as more infectious, and potentially more deadly, existing vaccines have been found to be effective against the variant, although health experts are concerned that the United States may not be able to administer vaccines fast enough to avoid another surge. Cases of the more infectious P.1 COVID-19 variant first identified in Brazil have also been on the rise nationwide, as Massachusetts now accounts for about a quarter of cases of the variant, at 58, followed by Florida’s 55 cases.
In a piece by Kaiser Health News, the impact of COVID-19 on the heart of an athlete was spotlighted. With heart inflammation, known as myocarditis, affecting as many as 1 in 5 people infected with SARS-CoV-2, concern has been noted on whether this could put athletes at risk for lifelong complications and death, particularly if athletes return to play too soon. Although screening studies of collegiate athletes over the past year have found generally lower numbers, authors say that these studies have been too small to provide an accurate measure of how likely athletes are to develop heart issues due to the virus.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512